Condition: Tuberculosis · Latent Tuberculosis · Sponsor: University of Oxford
To characterise the innate pulmonary immune response and respiratory microbiome after recent exposure to M.tb and to evaluate how differences determine the outcome of M.tb exposure
This description comes directly from the study's public registry record.
Timothy Fredsgaard-Jones, MBBS · +44 (0)1865 611385 · timothy.fredsgaard-jones@ndm.ox.ac.uk
Always discuss trial participation with your own doctor first.
| Churchill Hospital | Oxford, Oxfordshire, United Kingdom | Recruiting |
| Centre for Clinical Vaccinology and Tropical Medicine | Oxford, Oxon, United Kingdom | Recruiting |
| Grove Building, Royal Free NHS Foundation Trust | London, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06526689